IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
IQVIA Holdings Inc. (NYSE:IQV) is set to announce its first-quarter 2023 financial results on April 27, 2023, before market open. The management team will host a conference call and webcast at 9:00 a.m. Eastern Time to discuss these results. Investors can access the earnings release and financial data on the IQVIA Investor Relations website. To join the live event, participants must register in advance through a provided link, receiving confirmation with call details afterward. A replay of the webcast will be available two hours post-event. With around 86,000 employees across 100 countries, IQVIA specializes in advanced analytics, technology, and clinical research services for the life sciences sector, aiming to enhance healthcare outcomes through data-driven insights.
- Announcement of first-quarter 2023 financial results may indicate strong performance.
- Webcast and conference call provide transparency to investors.
- None.
To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants can connect to the call using the information provided in the confirmation email and will be placed directly into the call.
A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit http://ir.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
IQVIAFIN
View source version on businesswire.com: https://www.businesswire.com/news/home/20230406005469/en/
+1.973.316.3828
+1.919.780.3221
Source:
FAQ
When will IQVIA announce its first-quarter 2023 financial results?
What time is the IQVIA conference call scheduled for?
Where can I access IQVIA's earnings release and financial information?
How can I join the IQVIA conference call?